Drug Profile

Clobetasol propionate foam (Olux) - Stiefel Laboratories

Alternative Names: Clarelux; Clobetasol propionate foam 0.05%; Clobetasol thermophobic mousse; Olux

Latest Information Update: 09 Dec 2021

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Stiefel Laboratories
Class Anti-inflammatories; Antipsoriatics; Antiulcers; Fluorinated steroids; Glucocorticoids; Halogenated hydrocarbons; Propionates
Mechanism of Action Steroid receptor agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Marketed Psoriasis; Skin disorders

Most Recent Events

22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
28 Dec 2006 Connetics Corporation has been acquired and merged into Stiefel Laboratories
16 Feb 2006 Launched for Psoriasis in Italy (Topical)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com